Preclinical development of HIvax: Human survivin highly immunogenic vaccines

Our previous work involved the development of a recombinant fowlpox virus encoding survivin (FP-surv) vaccine that was evaluated for efficacy in mesothelioma mouse models. Results showed that FP-surv vaccination generated significant immune responses, which led to delayed tumor growth and improved a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Hoffmann, Peter R, Panigada, Maddalena, Soprana, Elisa, Terry, Frances, Bandar, Ivo Sah, Napolitano, Andrea, Rose, Aaron H, Hoffmann, Fukun W, Ndhlovu, Lishomwa C, Belcaid, Mahdi, Moise, Lenny, De Groot, Anne S, Carbone, Michele, Gaudino, Giovanni, Matsui, Takashi, Siccardi, Antonio, Bertino, Pietro
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514257/
https://ncbi.nlm.nih.gov/pubmed/26042612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1050572
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares